1. The Changes of Platelet Membrane Glycoprotein Levels in Peripheral Blood of Patients with Gastric Cancer and Its Influencing Factors.
- Author
-
CHEN Xiao-qun, JIN Cong-guo, LI jia, SHEN Wen-xiang, YAO Qian, and WU Zhi-ping
- Subjects
- *
GLYCOPROTEINS , *GASTROINTESTINAL cancer , *BLOOD flow measurement , *BLOOD platelets , *BIOLOGICAL membranes - Abstract
Objective To explore the clinical significance of the changes of platelet membrane glycoprotein levels in peripheral blood of patients with gastric cancer and its influencing factors. Methods The levels of platelet membrane glycoproteins (CD62p and CD63) in peripheral blood of 87 patients with gastric cancer were measured by flow cytometry (FCM). 40 healthy people were served as control. Statistical analysis was performed by using the SPSS 10.0 software package. Results The levels of platelet membrane glycoproteins in peripheral blood in patients with gastric cancer [CD62p: (4.15 ± 1.42) % and CD63 (4.72 ± 1.54) %] were significantly higher than controls [CD62p (1.54 ± 0.44) % and CD63 (1.23 ± 0.34) %] P < 0.01. The levels of platelets membrane glycoproteins in peripheral blood in patients with gastric cancer were significantly associated with clinical stage [CD62p (2.80 ±0.63) versus (4.76 ± 1.25); CD63 (3.28 ± 0.70) versus (5.36 ±1.37], operation [(CD62p:3.49 ± 1.21) versus (4.86 ± 1.28), (3.98 ± 1.31) versus (5.51 ± 1.38)], metastasis [CD62p (4.94 ±1.07) versus (3.31 ± 1.25); CD63 (5.55 ± 1.19) versus (3.82 ± 1.38)], while were not influenced by gender and pathological types. Conclusion Detecting the levels of platelets membrane glycoprotein in peripheral blood may dynamically monitor the progression and prognosis of gastric cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2014